the induction of the inhalation theraphy of hypoxic gas for the congenital heart disease patients with increased pulmonary flow

the induction of the inhalation theraphy of hypoxic gas for the congenital heart disease patients with increased pulmonary flow - hypoxic gas inhalation theraphy for the congenital heart disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012708

Enrollment

Registered

2013-12-26

Start date

2011-04-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenital heart disease with increased pulmonary blood flow

Interventions

inhalation of hypoxic gas for the congenital heart disease patients with increased pulmonary blood flow

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the congenital heart disease patients with increased pulmonary blood flow who cannot be controlled adequate pulmonary blood flow by conventional thrapy

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
adverse events	—

Secondary

Measure	Time frame
clinical efficacy of the therapy during perioperative period	—

Countries

Japan

Contacts

Public ContactHiroshi Katayama

Osaka Medical College Deparment of Pediatrics

ped100@poh.osaka-med.ac.jp072-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026